We are thrilled to see our study about ZBTB7A in basal breast cancer is out in @CellReports . We identified ZBTB7A as an novel interactor and regulator of KDM5 using CRISPR screen, and characterized its functional impact on NFkB pathway. Congrats to all!

🎃Polyak lab is getting ready for the MCO halloween pumpkin decoration contest! Huge shoutout to @MarieAnneGoyet1 and Andriana who made this piece of work based on the lab logo! Science and creativity go hand in hand!

@DFCI_BreastOnc @DanaFarberNews @DanaFarber

RT @yan_pengze: Thrilled to share that my aging and breast cancer paper is now published in Cancer Cell! 🎉 In this study, we identified “Mi…

@nellage @ZheqiL @MarieAnneGoyet1 @CFCE_DanaFarber @DFCI_BreastOnc @DanaFarberNews

Our study characterizing breast cancer brain metastasis is officially out in @PNASNews. We reproted breast cancer-stromal cells interaction induces resistance to HER2-targeting agents via bulky glycoproteins. Congrats to @MarieAnneGoyet1 and @nellage.

We are thrilled to announce that Nelly has been elected as a member of the prestigious American Academy of Arts and Sciences. Congratulations! We're so very proud of you!@nellage @DanaFarber @DanaFarberNews

@DFCI_BreastOnc @DanaFarberNews @nellage @ZheqiL @Otto_DFCI @MarieAnneGoyet1 @CarlosArteagaMD @TariKingMD @jenniferbellon2 @DrEricWiner

@IBC_DanaFarber @DFCI_BreastOnc @DanaFarberNews @nellage @FilipaLynce @EMittendorfMD @stolaney1 @ZheqiL @DrEricWiner @TariKingMD @janebrockmd @BalkoLab

Our resource paper on TNBC omic is officially out in @CellReports. We dissected TNBC heterogeneity with deep multiomic profiling on 34 TNBC cell lines and identified drivers of TNBC classification. Congrats to all! @nellage

@DanaFarberNews @DFCI_BreastOnc @nlinmd @AnnPartridgeMD

Congrats Nelly for receiving the 2023 #AACR Distinguished Lectureship in Breast Cancer Research Award! We take immense pride in this remarkable achievement, and we remain dedicated to our ongoing efforts in the fight against breast cancer.

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for TNBC is out in @MCT_AACR today. Congrats to all the coauthors! And of course a lot more to be explored in the future. @nellage

Today is the 25th anniversary of the Polyak Lab. With deep gratitude, we are honoring the collective contributions of members, alumni, and Nelly. Your commitment has fueled our success and shaped a remarkable journey of fighting against breast cancer.

We are very happy to see graduate student Ben from our lab successfully defended his PhD thesis last week. Ben works on KDM5 modulator in breast cancer over the last fives years. Congrats, Dr. Diciaccio! And looking forward to the paper. 🎓